Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Hospitals

 

Efficiency innovations becoming added-value for oxygen suppliers

Many oxygen suppliers have been continuously hostile to innovation that could make delivery more efficient, HBI hears. The pandemic has renewed attention on supply, pricing and patient outcomes leading to some to reassess the approach. HBI speaks to one medical device company that claims to save up to 80% of oxygen for an inpatient. 

NMC CEO: Any sale will be a competitive, traditional process

Will the creditors of NMC Healthcare, the GCC's largest for-profit healthcare operator which has been in administration since April 2020, choose a sale of its core UAE business in the next 3-6 months or a longer-term, creditor-led restructuring? We talk exclusively to NMC CEO Michael Davis and UAE sources. A 'fire sale' of parts of its core UAE business now seems entirely off the table.

Ameos “prepares for sale or refinancing”

Multiple sources tell HBI that DACH psychiatry and acute hospital group Ameos is preparing for sale or refinancing. The group vehemently denies it is preparing for sale.

NHS uses COVID surge capacity amidst private pay resurgence

NHS England trusts have triggered clauses granting full access to private hospital capacity in some areas as COVID-19 hospitalisations soar, amidst controversy over the ramp-up of private pay activity - although private operators tell HBI they are focusing on time-critical surgery and cancer care.

Hungary’s consolidators grow through COVID as ‘grey’ market formalises

Hungary's largest private acute care operators continued double-digit revenue growth of previous years in 2020 despite COVID-19, HBI can reveal. Recent analysis by analysts shows much of the sector's pre-pandemic growth may have been enhanced by capturing the 'grey' market of previously under-the-table private pay.

$3bn Imaging AI sector will re-shape industry after watershed 2019/20

Imaging AI solutions which can read images just as well as radiologists are now demonstrably effective medical products that will revolutionise the medical imaging industry forever. $1.5bn in VC funding has been ploughed into companies developing solutions whose tech promises to transform diagnosis and improve operational efficiency. We talk to seven of them who've commercialised products in 2019/20, operators using them, and look at the sector in detail in this long-read feature.

Find Us